AMENDMENT NO. 1 TO SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • April 30th, 2013 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amendment No. 1 to Sponsored Research Agreement, dated April 29, 2013 (the “First Amendment”), is entered into by and among INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its registered office at 18 Desbrosses Street, New York, NY 10013, USA (“Sponsor”), Dipartimento di Chimica e Tecnologia del Farmaco of the Università di Perugia, Via del Liceo, 1, Perugia, Italy 06123 (“University”), and Professor Roberto Pellicciari of the Dipartimento di Chimica e Tecnologia del Farmaco at the University, Via del Liceo, 1, Perugia, Italy 06123 (“Principal Investigator”).
AMENDMENT NO. 1 TO CONSULTING AND IP AGREEMENTConsulting and Ip Agreement • April 30th, 2013 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 to Consulting and IP Agreement, dated April 29, 2013 (the “First Amendment”), is entered into by and between INTERCEPT PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware, with its registered office at 18 Desbrosses Street, New York, NY 10013, USA (“INTERCEPT”) on the one hand and ROBERTO PELLICCIARI (“Consultant”), residing at Via U. Rocchi, 60, Perugia, Italy 06123, on the other hand.
